Pharma & Biotech - Page 9

Merck (MRK) has announced that its flagship cancer drug Keytruda has achieved a landmark result in the treatment of a specific endometrial cancer subtype. The drug became the first PD-1 inhibitor to

Pharma’s third-party logistics sector is undergoing a fundamental transformation, moving well beyond its traditional role of shifting pallets through wholesale distribution chains. The industry is now contending with smaller patient populations, highly

Celcuity has secured FDA approval for gedatolisib, now branded as Revtorpyk, marking a significant milestone in the treatment of hormone receptor-positive, HER2-negative breast cancer. The regulator approved Revtorpyk specifically for previously treated

The Trump administration’s April 2026 announcement of a 100% base levy on imported APIs and patented drugs has forced a sweeping re-evaluation of pharmaceutical supply chains across the industry. Reshoring pharmaceutical manufacturing

AstraZeneca (AZN) has signed a global exclusive licence agreement with Dizal to acquire worldwide rights to develop and commercialise Zegfrovy, also known as sunvozertinib. The deal comprises a $600 million upfront payment

The pharmaceutical distribution sector is undergoing a significant transformation, driven by the need to balance highly targeted delivery models with large-scale operational demands. Modern drug supply chains are increasingly complex, requiring distributors

GSK is preparing to seek FDA accelerated approval for its cancer drug Jemperli after a phase 2 trial delivered a significant clinical win in a high-profile cancer indication. Interim results from the

Insulet Corporation (NASDAQ: PODD), maker of the Omnipod tubeless insulin pump, has announced a global partnership with mental health app Calm to support the emotional wellbeing of people living with diabetes. The

Lupin Pharmaceuticals, the U.S. unit of India-based Lupin Limited, has issued a voluntary recall of more than 2.5 million bottles of prescription eye drops following the discovery of an undisclosed contaminant. The

Pharmaceutical manufacturers are increasingly turning to reusable plastic pallets as pressure mounts to deliver high-value products safely, sustainably, and efficiently. ORBIS Corporation strategic account manager Matt Marchetti says the shift reflects growing